BioSpace News Archive

Teva Pharmaceuticals USA, Inc. an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) has approved an autoinjector device for AJOVY® (fremanezumab-vfrm) injection.

Three-Day Event Will Galvanize Thought Leaders, Researchers and Community Members Around Topics That Will Change the Culture and Reality of Paralysis

Elanco Animal Health Incorporated will announce its 2019 fourth quarter financial results on Wednesday, February 19, 2020.

Covalon Technologies Ltd., an advanced medical technologies company, announces its fiscal 2019 year-end results and plans for fiscal 2020.

Biohaven Pharmaceutical Holding Company Ltd., a clinical‑stage biopharmaceutical company with a portfolio of innovative, late‑stage product candidates targeting neurological diseases, including rare disorders, announced that it has commenced an underwritten public offering of $250 million of its common shares.

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the quarter and nine months ended December 31, 2019, after the close of market on Monday, February 3, 2020.

Withdraws Nomination of Dr. Bruce Hanna, Ph.D.; Current Nominees Rebecca Fischer and Barry Weiner Remain.

Denali Therapeutics Inc. announced the pricing of its underwritten public offering of 7,826,087 shares of its common stock at a price to the public of $23.00 per share.

NuCana plc (NCNA) announced that the first patients have been dosed in its Phase III study of Acelarin (NUC-1031) plus cisplatin for the first-line treatment of patients with biliary tract cancer and that the study design is being presented at the ASCO-GI Conference in San Francisco.

The Blood Connection, your community blood center, is proud to serve the Charleston community through free therapeutic phlebotomy.